Steep Hill (XCNQ:STPH) EV-to-EBIT : 4.56 (As of May. 17, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Steep Hill EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Steep Hill's Enterprise Value is C$-2.11 Mil. Steep Hill's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.46 Mil. Therefore, Steep Hill's EV-to-EBIT for today is 4.56.

The historical rank and industry rank for Steep Hill's EV-to-EBIT or its related term are showing as below:

XCNQ:STPH' s EV-to-EBIT Range Over the Past 10 Years
Min: -1.02 Med: 0.25 Max: 4.56
Current: 4.56

During the past 5 years, the highest EV-to-EBIT of Steep Hill was 4.56. The lowest was -1.02. And the median was 0.25.

XCNQ:STPH's EV-to-EBIT is ranked better than
91.17% of 668 companies
in the Drug Manufacturers industry
Industry Median: 17.9 vs XCNQ:STPH: 4.56

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Steep Hill's Enterprise Value for the quarter that ended in Dec. 2023 was C$-2.03 Mil. Steep Hill's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.46 Mil. Steep Hill's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 22.78%.

Steep Hill EV-to-EBIT Historical Data

The historical data trend for Steep Hill's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steep Hill EV-to-EBIT Chart

Steep Hill Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

-3.36

-0.81

0.15

4.40

Steep Hill Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial													0.15	0.59	0.58	0.55	4.40

Competitive Comparison of Steep Hill's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Steep Hill's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Steep Hill's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Steep Hill's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Steep Hill's EV-to-EBIT falls into.

Steep Hill EV-to-EBIT Calculation

Steep Hill's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	-2.109	/	-0.462
	=	4.56

Steep Hill's current Enterprise Value is C$-2.11 Mil.
Steep Hill's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.46 Mil.

Steep Hill (XCNQ:STPH) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Steep Hill's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-0.462	/	-2.027749
	=	22.78 %

Steep Hill's Enterprise Value for the quarter that ended in Dec. 2023 was C$-2.03 Mil.
Steep Hill's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.46 Mil.

Steep Hill EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Steep Hill's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Steep Hill (XCNQ:STPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Steep Hill Inc (XCNQ:STPH) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

120 Adelaide Street West, Suite 2500, Toronto, ON, CAN, M5H 1T1

Website

https://www.steephill.com

Steep Hill Inc is a science and technology health and wellness company focused on the hemp markets inclusive of plant-based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals. Currently the company, through its subsidiaries holds three industrial hemp licences for the purposes of supplying the global market with medicinal and wellness cannabidiol and other cannabinoid-based products.

Steep Hill (XCNQ:STPH) Headlines

No Headlines